Michael Ayanbadejo, MD, MPH

Dr. Michael Ayanbadejo is Chief Innovation and Strategy Officer of Chia Dex Ventures, where he leads the firm’s value-based payment and population health initiatives. A trained physician, he has nearly two decades of experience across clinical medicine, clinical research, population health, value-based care and healthcare operations.

He began his career practicing medicine across diverse communities in Nigeria, where he learned that effective care depends on understanding a patient’s environment, social context and the barriers that shape health outcomes. He went on to hospital-based clinical research, contributing to neuroscience, stroke, cardiovascular, psychiatric and multi-hospital research programmes.

Moving into healthcare innovation and strategy, he worked on transformation initiatives in population health, patient-centered medical homes, chronic disease management, predictive analytics, health equity and care redesign, with a focus on closing the gaps that data reveals: transportation, access to medication, food insecurity, fragmented behavioral health care and health literacy.

As Director of Clinical Services at a federally qualified health center, he led integrated care across medical, behavioral health, dental and care management services, strengthening care coordination, modernizing workflows and designing sustainable value-based care models. He is also the founder and chief executive of SparrowVision Health Group, and advises health systems, practices and emerging healthcare enterprises on care redesign, operations and innovation strategy.